- Pharmaceutical Outsourcing: “Seqens Group Opens Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- WPKZ.net: “Seqens announces in R&D Lab in Devens” (Jan. 31, 2023)
-
- JamieEldridgeMA (via Twitter): “Great to attend the ribbon-cutting of @Seqens_CDMO R&D Center at #Devens today! @RepDanSenaMA & I were honored to join #French Consul General Soykurt in welcoming #Seqens as part of an emerging #biotech cluster at #Devens, bravo DEC & @MassDev ! TY @MALifeSciences for attending!” (Jan. 31, 2023)
-
-
- Consulate of France in Boston (via Twitter): “At the inauguration of @Seqens‘s new office in Devens today in the presence of President Pierre Luzeau and GC @SoykurtM. This is a major milestone for @Seqens_CDMO‘s presence in Boston and its commitment to the innovation ecosystems in 🇫🇷 and in the 🇺🇸. Congratulations! t.co/I5Ao7hwIGJ” (Jan. 31, 2023)
- Mustafa Soykurt (via Twitter): “QT @FranceinBoston: Très belle inauguration du nouveau centre de recherche et développement de @Seqens, très bel exemple de l’excellence et du savoir-faire français. Félicitations ! ; A l’inauguration des nouveaux locaux de @Seqens à Devens aujourd’hui en présence du Président Pierre Luzeau et du CG @SoykurtM. Une
- étape importante pour la présence de @Seqens_CDMO à Boston et son engagement envers les écosystèmes d’innovation en 🇫🇷 et aux 🇺🇸. Félicitations! t.co/zo1EKgef4Q” (Jan. 31, 2023)
- Contract Pharma: “Seqens Opens Flagship R&D Center in Greater Boston Invests $5 million in a state-of-the-art, 15,000 sq.-ft. R&D center in Devens, MA” (Jan. 31, 2023)
- Contract Pharma (via Facebook): “Seqens Group, a developer and manufacturer of active pharmaceutical ingredients #APIs and #intermediates, has opened Seqens Boston R&D Center, a state-of-the-art, 15,000 sq.-ft. R&D center in Devens, MA. The new facility will provide advanced capabilities for the discovery and development of new drugs and therapeutics. https://hubs.li/Q01zNdVY0” (Jan. 31, 2023)
- Contract Pharma (via Twitter): “.@seqens_group, a developer and manufacturer of #APIs and #intermediates, opened a state-of-the-art, 15,000 sq.-ft. R&D center in Devens, MA to provide advanced capabilities for the discovery and development of new drugs and therapeutics. https://hubs.li/Q01zNd980
- Pharmaceutical Daily (via Facebook): “Multi-million Dollar Investment Signals Commitment to U.S. Market; Creates R&D Center of Excellence in Pharmaceutical Development and Manufacture NEWBURYPORT, Mass.–(BUSINESS WIRE)–#CDMO–Seqens Group, an integrated leader in the development and manufacture of active pharmaceutical ingredients (APIs) and intermediates, today announced that it has opened Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. Serving as one of the company’s global centers of excellence, the new facility will bring customers advanced capabilities for the discovery and development of new drugs and therapeutics….https://pharmaceuticaldaily.com/seqens-group-opens…/” (Jan. 31, 2023)
- Pharmaceutical Daily (via Twitter): “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston t.co/W4OUWdVtAU” (Jan. 31, 2023)
- Pharmaceutical Daily: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Yahoo!Finance: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- ChannelBiz: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- World Pharma Today: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Epicos: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Benzinga: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- TMCnet.com: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- StreetInsider: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Associated Press: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Silicon Investor: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Le Lezard: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Startup365: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- ADVFN Canada: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- NewsR: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Chronicle-Tribune: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- The Derrick: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Metro Latino USA: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston” (Jan. 31, 2023)
- Scrip Pharma Intelligence: “Executives On The Move: AVEO Pharmaceuticals, Everest Medicines and More: Recent executive changes in the industry include C-suite changes at Aveo Pharmaceuticals and Scandion Oncology. Meanwhile, new directors were appointed at Akston Biosciences and Everest Medicines” (Jan. 26, 2023)
- McKnight’s Senior Living: People in the news, Jan. 24: Emily McGrath” (Jan. 24, 2023)
- PharmTech Focus: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 24, 2023)
- PharmTech Focus (via LinkedIn): “Akston Biosciences Corporation Strengthens Board with Addition of John T. Preston” (Jan. 24, 2023)
- World Business Outlook (via Twitter): “Akston Biosciences Corporation, one of the clinical-stage biotechnology company, recently announced that John T. Preston, a founder of TEM Capital, has joined its Board of Directors. https://tinyurl.com/2yhtrbk2 #wbo #Biotechnology #business #technology #Netherlands” (Jan. 24, 2023)
- World Business Outlook: “Akston Biosciences appoints John T. Preston as Board of Directors” (Jan. 24, 2023)
- Talent4Boards: “Akston Biosciences appoints John Preston to its Board of Directors” (Jan. 24, 2023)
- North Andover Eagle-Tribune: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- HealthManagement.org: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Financial Content: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- BioSpace: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Yahoo! Finance: “Akston iosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- WV News: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Pharmaceutical Daily: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Pharmaceutical Daily (via Twitter): “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Peru Tribune: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Joplin Globe: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Metro Latino USA: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- CityBiz: “Akston Biosciences Appoints John T. Preston to Board” (Jan. 23, 2023)
- StreetInsider: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Merrill Edge: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Le Lezard: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- ADVFN Canada: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- NewsR: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Associated Press: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Impact: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Daily Item: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Chronicle-Tribune: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Four Corners News-Sun: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Manchester Times: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Eagle Tribune: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Becker’s Hospital Review: “10 largest independent hospitals in America” (Jan. 20, 2023)
- MedicalXpress: “Older adults benefit when health care providers and affordable housing sites partner, finds research” (Jan. 19, 2023)
- La Revue Gauche: “Older adults benefit when health care providers and affordable housing sites partner: Research finds that seniors have lower rates of hospitalization and readmission” (Jan. 19, 2023)
- Public News Time: “Older adults benefit when health care providers and affordable housing sites partner, finds research” (Jan. 19, 2023)
- Mirage: “Delirium Care Expanded Through Remote Protocols” (Jan. 18. 2023)
- Digital Journal: “Freeze Drying Equipment Market Demand Analysis 2022 Growth Statistics, Revenue Estimates, COVID-19 Impact, Industry Size, Global Share, Emerging Trends, Top Leading Players” (Jan. 18, 2023)
- MedicalXpress: “Remote protocols broaden reach of delirium care” (Jan. 16, 2023)
- Harvard Medical School: “News & Research: Remote Protocols Broaden Reach of Delirium Care: Modified, extended program has potential to improve hospital care of older adults” (Jan. 16, 2023)
- French Post-U.S.: “Remote protocols expand the scope of delirium care” (Jan. 13, 2023)
- Worcester Business Journal: “French pharmaceutical company to open 15K-sq.-ft. Devens research center” (Jan. 11, 2023)
- Worcester Business Journal: “Pharmaceutical company to unveil Devens research center this month” (Jan. 11, 2023)
- ISCI365.com: “Salicylate Market Will Witness Significant Growth, Incredible Demand, Prominent Investment in 2023-2029” (Jan. 11, 2023)
- McKnight’s Senior Living: “People in the news, Jan. 10: Hebrew SeniorLife appoints Ernest I. Mandel, MD, new chief medical officer” (Jan. 10, 2023)
- ISCI365.com: “Salicylate Market Will Witness Significant Growth, Incredible Demand, Prominent Investment in 2023-2029” (Jan. 3, 2023)
